LABU Direxion Daily S&P Biotech Bull 3x Shares ETF
- 113.340
- -4.050-3.45%
Moderna Says European Patent Office Decided To Maintain Validity Of Co's EP949 Patent, One Of The Key Patents Currently Asserted Against Pfizer & BioNTech In Various European National Courts
Moderna Says European Patent Office Decided To Maintain Validity Of Co's EP949 Patent, One Of The Key Patents Currently Asserted Against Pfizer & BioNTech In Various European National Courts
'Moderna Wins Case In Patent Dispute With Pfizer And BioNTech Over Covid Jab; Decision Is A Boon For The MRNA-Vaccine Maker In Its Legal Fight To Recoup Pandemic Profits From Rivals' - Financial Times
Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its Covid-19 vaccine, in a boon for the mRNA-vaccine maker in its ongoing legal fight to recoup pandem
Check Out What Whales Are Doing With MRNA
Investors with a lot of money to spend have taken a bullish stance on Moderna (NASDAQ:MRNA).And retail traders should know.We noticed this today when the trades showed up on publicly available options
Daily ticket tracking | GameStop rose more than 10% before the market, and call orders are booming; Faraday's future options transactions surged, and bulls are bullish to $2
Faraday's future overnight options traded 800,000, a surge of nearly 13 times from the average daily turnover, and the bullish ratio fell to 65%. Both long and short trades are active on the options chain. Calls and $0.5 puts due today are popular. The trading volume was 158,000 and 137,000, respectively, and the unclosed volume was 22,000 and 34,000, respectively.
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
On Sunday, Pfizer (NYSE:PFE) and AstraZeneca Plc (NASDAQ:AZN) were among the pharmaceutical companies who announced they will be investing a total of nearly $1 billion in their operations in France, j
Wedbush Reiterates Neutral on Alpine Immune Sciences, Maintains $65 Price Target
Wedbush analyst Robert Driscoll reiterates Alpine Immune Sciences (NASDAQ:ALPN) with a Neutral and maintains $65 price target.
Alpine Immune Sciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/16/2024 0.05% Wedbush → $65 Reiterates Neutral → Neutral 04/16/2024 — TD Cowen Downgrades Buy → Hold 0
Duquesne Family Office Top Q1 Buys, Cuts: Coherent, Eli Lilly, Others
Smart Money Is Betting Big In MRNA Options
Whales with a lot of money to spend have taken a noticeably bullish stance on Moderna.
Short Interest in S&P 500 Healthcare Sector Dips in April, Biotechnology Companies Most Shorted
Novavax's Options: A Look at What the Big Money Is Thinking
Investors with a lot of money to spend have taken a bullish stance on Novavax (NASDAQ:NVAX).And retail traders should know.We noticed this today when the trades showed up on publicly available options
Jim Cramer: This Industrial Company Is 'Absolutely Terrific', Recommends Buying Modine Manufacturing
On CNBC's "Mad Money Lightning Round," Jim Cramer believes in Moderna, Inc. (NASDAQ:MRNA).On May 14, Evercore ISI Group analyst Cory Kasimov initiated coverage on Moderna with an In-Line rating and an
10 Health Care Stocks With Whale Alerts In Today's Session
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
18 Analysts Have This To Say About Crinetics Pharmaceuticals
In the last three months, 18 analysts have published ratings on Crinetics Pharmaceuticals (NASDAQ:CRNX), offering a diverse range of perspectives from bullish to bearish.The table below provides a con
New Hotter Inflation Data – Momo Buys The Dip, Fed Blunder Shows Up In Roaring Meme Stocks
To gain an edge, this is what you need to know today. Hotter Inflation Data Please click here for an enlarged chart of SPDR S&P 500 ETF Trust (NYSE:SPY) which represents the benchmark stock market in
Shares of 'Meme Stocks' and High-short Interest Stocks Are Trading Higher Amid a Renewed Surge in the Space After Popular Retail Trader 'Roaring Kitty' Returned to Social Media.
Shares of 'Meme Stocks' and High-short Interest Stocks Are Trading Higher Amid a Renewed Surge in the Space After Popular Retail Trader 'Roaring Kitty' Returned to Social Media.
Planet Fitness To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.Roth MKM cu
Crinetics Pharmaceuticals Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/14/2024 35.61% Cantor Fitzgerald → $65 Reiterates Overweight → Overweight 05/10/2024 25.18% HC Wainwrig
US Stock Preview | Meme stocks continue to “boom” before the market! Game Station and AMC Cinemas both increased by about 100%
Damo: The US CPI cooling in April is just the beginning; inflation will slow down at an accelerated pace in the second half of the year; institutions: if inflation eases, the US dollar and US bond yields may fall; can they rise another 50%? Nvidia's new earnings report is about to be released, and the Wall Street price target is astonishing.
Piper Sandler Maintains Overweight on Natera, Raises Price Target to $120
Piper Sandler analyst David Westenberg maintains Natera (NASDAQ:NTRA) with a Overweight and raises the price target from $110 to $120.